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The leukemoid reaction is defined by the presence in peripheral blood 
of white cells above 50,000/mm3 or neutrophils above 30,000/mm3. The 
frequency varies between 1.3 and 15% of newborns admitted to neonatal 
intensive care units [1]. It usually appears during the first two weeks of 
life and more frequently during the first four days, the duration is about 
8.5 days [2]. In extremely premature, this process is produced by an 
inflammatory response that active cytokines who increased granulocyte 
colony-stimulating factors (G-CSF). These induce the production of 
neutrophils that cause hyperleukocytosis. 
These cytokines are produced in diseases related with prematurity 
such as brain white matter injury, respiratory failure with progression to 
bronchopulmonary dysplasia or necrotizing enterocolitis. The leukemoid 
reaction is also associated with the administration of neonatal steroids, 
infections, severe anemia and bronchopulmonary dysplasia [2,3].
Case 1
A 28-week gestational female newborn admitted to the neonatal 
intensive care unit for extreme prematurity and respiratory distress. It was 
the fifth gestation of a 36 years old woman. She had pregestational diabetes 
mellitus treated with insulin, morbid obesity, arterial hypertension and 
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polycystic ovarian syndrome. The ultrasounds were normal, and maternal 
serologies were negative. A dose of corticosteroids (intramuscular 
betamethasone) was given for pulmonary maturation 24 hours before 
birth. The delivery was eutocic, of cephalic presentation and 7 hours 
amniorrhexis. Apgar score was 7/9. Umbilical artery pH was 6.91. She 
required resuscitation with continuous positive pressure in the delivery room.
On the CBC, white blood cell count was 43,740/mm3 (65% S, 3% NS, 
1% Eo, 24% L, 7% Mo), and the C Reactive Protein (CRP) was 35.8 mg/L. It 
was carried out a microbiological study (hemoculture, peripheral smears) 
and empiric antibiotic treatment with ampicillin and gentamicin for 10 
days. It was observed a progressive decrease in CRP from the 4th day of life. 
In contrast, there was a progressive elevation of leukocytes (maximum of 
109,000 /mm3 on the 5th day of life) (Table 1). A peripheral blood study 
didn’t shown malignancy.
Case 2
A 28-week gestational male newborn admitted to the neonatal intensive 
care unit for extreme prematurity and respiratory distress. It was the third 
gestation of a 28 years old woman. The gestation control was poor and she 
was amphetamine consumer. 
1dol a 2dol a 3dol a 4dol a 5dol a 6dol a 9dol a 13dol a
Leukocytes (mm3)
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Monocytes
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Eosinophils (%)
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1
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Basophiles (%)
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0%
0%
0%
0% 0%
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0%
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CRP (mg/L)
Case 1
Case 2
35,8
10,4
16,2
6,3 3.3
3
2
1,6
0,7 0.5
Table 1: Evolution of the leukocyte formula and C-reactive protein (CRP) in both newborns.
*dol:days of life
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Urine culture on the delivery day was positive for E. Coli sensitive to 
gentamicin. Corticosteroids were given for pulmonary maturation 24 
hours before birth. The delivery was eutocic, of cephalic presentation, and 
50 hours amniorrhexis. Apgar score was 7/9. Umbilical artery pH was 
7.39. He was born vigorous but he stank. No resuscitation was required 
and continuous positive pressure was initiated.
Chorioamnionitis was suspected and peripheral smears and 
hemoculture were collected. Empiric antibiotic treatment with ampicillin 
and gentamicin was initiated. At the third day, due to alterations in the 
white blood cell count, the antibiotherapy was changed to ampicillin 
and cefotaxime for two more days. Positive cultures were obtained for 
Mycoplasma hominis and Ureaplasma urealyticum in the smears of the 
fetal and maternal faces of the placenta and the otic smear. The white 
blood cell count increased up to 7,340/mm3 on the fifth day of life, without 
elevation of the CRP value (Table 1). A peripheral blood study didn’t 
shown malignancy.
Commentary
In both cases, it was suspicion of infection and antibiotic treatment was 
given early. A differential diagnosis with onco-hematologic pathology was 
performed due the progressive increase in leukocytes >50,000/mm3, with 
no signs of malignancy in any of the cases.
In the case of a newborn with extreme hyperleukocytosis, if clinical 
history, physical examination and peripheral blood extension study are 
not indicative of leukemia, myeloproliferative disorder or a leukocyte 
adhesion defect, expectant management may be maintained [3,4].
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